[go: up one dir, main page]

AU4846697A - Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them - Google Patents

Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them

Info

Publication number
AU4846697A
AU4846697A AU48466/97A AU4846697A AU4846697A AU 4846697 A AU4846697 A AU 4846697A AU 48466/97 A AU48466/97 A AU 48466/97A AU 4846697 A AU4846697 A AU 4846697A AU 4846697 A AU4846697 A AU 4846697A
Authority
AU
Australia
Prior art keywords
compositions
processes
preparation
purine derivatives
substituted purine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU48466/97A
Other versions
AU728865B2 (en
Inventor
Gerhard Breipohl
Denis Carniato
Thomas Richard Gadek
Jean-Francois Gourvest
Jochen Knolle
Anuschirwan Peyman
Volkmar Wehner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Genentech Inc
Original Assignee
Hoechst AG
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG, Genentech Inc filed Critical Hoechst AG
Publication of AU4846697A publication Critical patent/AU4846697A/en
Application granted granted Critical
Publication of AU728865B2 publication Critical patent/AU728865B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU48466/97A 1996-12-20 1997-12-18 Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them Ceased AU728865B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19653646A DE19653646A1 (en) 1996-12-20 1996-12-20 Substituted purine derivatives, processes for their preparation, agents containing them and their use
DE19653646 1996-12-20

Publications (2)

Publication Number Publication Date
AU4846697A true AU4846697A (en) 1998-06-25
AU728865B2 AU728865B2 (en) 2001-01-18

Family

ID=7815761

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48466/97A Ceased AU728865B2 (en) 1996-12-20 1997-12-18 Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them

Country Status (22)

Country Link
EP (1) EP0853084B1 (en)
JP (1) JP4620190B2 (en)
KR (1) KR19980064655A (en)
CN (2) CN1495184A (en)
AR (1) AR010700A1 (en)
AT (1) ATE404562T1 (en)
AU (1) AU728865B2 (en)
BR (1) BR9706387A (en)
CA (1) CA2225366C (en)
CZ (1) CZ294437B6 (en)
DE (2) DE19653646A1 (en)
HK (1) HK1012190A1 (en)
HU (1) HUP9702507A3 (en)
ID (1) ID19254A (en)
IL (1) IL122642A0 (en)
NO (1) NO314583B1 (en)
NZ (1) NZ329431A (en)
PL (1) PL323969A1 (en)
RU (1) RU2228335C2 (en)
TR (1) TR199701647A2 (en)
TW (1) TW523515B (en)
ZA (1) ZA9711317B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4064059B2 (en) 1998-04-09 2008-03-19 明治製菓株式会社 Aminopiperidine derivatives as integrin αVβ3 antagonists
AU2209800A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia
JP3270834B2 (en) 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク Heteroaromatic bicyclic derivatives useful as anticancer agents
UA71945C2 (en) 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
EP1065208A1 (en) * 1999-07-02 2001-01-03 Aventis Pharma Deutschland GmbH Substituted purine derivatives as inhibitors of cell adhesion
EP1065207A1 (en) 1999-07-02 2001-01-03 Aventis Pharma Deutschland GmbH Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them
EP1209152A4 (en) 1999-08-05 2003-03-12 Meiji Seika Kaisha Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alpha v beta 3 antagonism
EP1176145A1 (en) * 2000-07-28 2002-01-30 Aventis Pharma Deutschland GmbH Novel guanidino derivatives as inhibitors of cell adhesion
DE10042655A1 (en) * 2000-08-31 2002-03-14 Aventis Pharma Gmbh Process for the preparation of inhibitors of cell adhesion
KR100438820B1 (en) * 2001-03-05 2004-07-05 삼성코닝 주식회사 Method for manufacturing compound semiconductor substrate of III-V group
CZ20033119A3 (en) 2001-04-24 2005-01-12 Merck Patent Gmbh Combination therapy using anti-angiogenic agents and TNF alpha
FR2847254B1 (en) * 2002-11-19 2005-01-28 Aventis Pharma Sa NOVEL VITRONECTIN RECEPTOR ANTAGONIST DERIVATIVES, PROCESS FOR PREPARING THEM, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS REFLECTING THEM
FR2870541B1 (en) 2004-05-18 2006-07-14 Proskelia Sas ANTIGONISTIC PYRIMIDINE DERIVATIVES OF VITRONECTIN RECEPTOR
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
EP2335733B1 (en) 2006-01-18 2014-08-06 Merck Patent GmbH Specific therapy using integrin ligands for treating cancer
KR20090108713A (en) 2007-01-18 2009-10-16 메르크 파텐트 게엠베하 Specific therapies and medicines for cancer treatment using integrin ligands
PL2206727T3 (en) 2007-10-11 2015-08-31 Daiichi Sankyo Co Ltd ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15
CA2705579A1 (en) * 2007-11-14 2009-05-22 Myriad Pharmaceuticals, Inc. Therapeutic compounds and their use in treating diseases and disorders
EP3699277A1 (en) 2009-04-09 2020-08-26 Daiichi Sankyo Company, Limited Anti-siglec-15 antibody
CN102448497A (en) 2009-05-25 2012-05-09 默克专利有限公司 Continuous administration of integrin ligands for treating cancer
CN103237813A (en) 2010-10-05 2013-08-07 第一三共株式会社 Antibody targeting osteoclast-elated protein Siglec-15
ES2660472T3 (en) 2012-03-30 2018-03-22 Daiichi Sankyo Company, Limited Anti-Siglec-15 antibody modified with CDR
CN107312039B (en) 2012-08-30 2019-06-25 江苏豪森药业集团有限公司 A kind of preparation method of tenofovir prodrug
KR20160147007A (en) 2014-05-30 2016-12-21 화이자 인코포레이티드 Carbonitrile derivatives as selective androgen receptor modulators
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4730696Y1 (en) * 1966-12-10 1972-09-13
JPS6396663A (en) * 1986-10-13 1988-04-27 Mita Ind Co Ltd Electrostatic charge image developing toner
JPS6396553A (en) * 1986-10-14 1988-04-27 Sekisui Chem Co Ltd Packing material
DE4129603A1 (en) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K CONDENSED 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THESE COMPOUNDS
MX9207334A (en) * 1991-12-18 1993-08-01 Glaxo Inc NUCLEIC ACIDS PEPTIDICS AND PHARMACEUTICAL FORMULATION CONTAINING THEM
FR2700337B1 (en) * 1993-01-11 1995-04-14 Lafon Labor Imidazopyridine-2-one derivatives, their preparation process and their use in therapy.
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
DE4405378A1 (en) * 1994-02-19 1995-08-24 Merck Patent Gmbh Adhesion receptor antagonists
US5554746A (en) * 1994-05-16 1996-09-10 Isis Pharmaceuticals, Inc. Lactam nucleic acids
US5929046A (en) * 1994-06-08 1999-07-27 Cancer Research Campaign Technology Limited Pyrimidine and purine derivatives and their use in treating tumour cells
US5994361A (en) * 1994-06-22 1999-11-30 Biochem Pharma Substituted purinyl derivatives with immunomodulating activity
PL318199A1 (en) * 1994-06-29 1997-05-26 Smithkline Beecham Corp Antagonists of vitronectin receptors
US5525606A (en) * 1994-08-01 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
WO1996020212A2 (en) * 1994-12-28 1996-07-04 Buchardt, Dorte Peptide nucleic acid incorporating a chiral backbone
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
JP2001518054A (en) * 1995-06-07 2001-10-09 パーセプティブ バイオシステムズ，インコーポレーテッド PNA-DNA chimera and PNA synthon for chimera synthesis
JPH1025294A (en) * 1996-03-26 1998-01-27 Akira Matsuda Fused heterocyclic derivative, method for producing the same, and therapeutic agent for malignant tumor containing the same
CA2249598A1 (en) * 1996-03-26 1997-10-02 Paul Joseph Gilligan Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives
GB9613021D0 (en) * 1996-06-21 1996-08-28 Pharmacia Spa Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
JP3306073B2 (en) * 1996-07-24 2002-07-24 ブヒャルト，ドルテ Peptide nucleic acids with increased binding affinity, sequence specificity and solubility
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2

Also Published As

Publication number Publication date
HU9702507D0 (en) 1998-03-02
CN1101816C (en) 2003-02-19
RU2228335C2 (en) 2004-05-10
TR199701647A3 (en) 1998-07-21
KR19980064655A (en) 1998-10-07
ID19254A (en) 1998-06-28
IL122642A0 (en) 1998-08-16
DE19653646A1 (en) 1998-06-25
EP0853084A2 (en) 1998-07-15
CN1495184A (en) 2004-05-12
NZ329431A (en) 2000-01-28
CN1193623A (en) 1998-09-23
HUP9702507A2 (en) 1999-05-28
PL323969A1 (en) 1998-06-22
NO975977L (en) 1998-06-22
ATE404562T1 (en) 2008-08-15
MX9710277A (en) 1998-10-31
TW523515B (en) 2003-03-11
NO314583B1 (en) 2003-04-14
HK1012190A1 (en) 1999-07-30
HUP9702507A3 (en) 1999-12-28
JPH10182645A (en) 1998-07-07
AU728865B2 (en) 2001-01-18
CA2225366C (en) 2006-10-10
CZ294437B6 (en) 2005-01-12
EP0853084B1 (en) 2008-08-13
DE59712958D1 (en) 2008-09-25
TR199701647A2 (en) 1998-07-21
AR010700A1 (en) 2000-06-28
NO975977D0 (en) 1997-12-19
CA2225366A1 (en) 1998-06-20
JP4620190B2 (en) 2011-01-26
BR9706387A (en) 2000-03-14
EP0853084A3 (en) 1998-09-09
CZ411497A3 (en) 1998-07-15
ZA9711317B (en) 1998-06-22

Similar Documents

Publication Publication Date Title
AU4846697A (en) Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
AU4867697A (en) Oxadiazoles, processes for preparing them and their use as pharmaceutical compositions
HUP0000658A3 (en) Sulphonamide derivatives, process for their preparation, and their use as medicaments
AU1756897A (en) Avermectin formulation
AU1925097A (en) Pyrimidin-4-one derivatives as pesticide
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
AU4679297A (en) 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals
AU4777097A (en) Novel piperidineketocarboxylic acid derivatives, their preparation and use
AU1457995A (en) Novel adenosine derivatives, preparation methods therefor, and pharmaceutical compositions containing same
AU2524497A (en) Size composition, method for its preparation, and use thereof
AU3352197A (en) Pyridyl-piperazinyl-phenyl-oxazolidinone derivatives and their use as antibacterials
AU1596097A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
AU2701697A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
AU6658596A (en) Substituted 1-phenyluracil derivatives, their preparation and their use as herbicides
AU4384297A (en) Antiviral compositions
AU5985198A (en) Enamel compositions, process for their preparation and their use
HUT75949A (en) 13-substituted milbemycin derivatives, their use as herbicids and herbicid compositions
AU4219197A (en) 3-substituted-d-homo-1,3,5,(10)-estratriene derivatives
AU3327097A (en) Laminate, process for its preparation and its use
AU1595997A (en) Thienoxazinone derivatives useful as antiviral agents
AU4509696A (en) 3-benzoylpyridine derivatives, their preparation and their use as herbicides
AU8031598A (en) 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them
AU8132094A (en) Khellactone derivatives and related compounds, process for their preparation and their use as antiviral and immunostimulating agents
HK1015763A1 (en) Benzoxazindione derivatives, process for their preparation and their use

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)